Prenatal Diagnosis
12
1
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (12)
Shifting Options Study
Sufentanil Pharmacokinetics After Intra Amniotic Injection
Normative Brain Volume Profiles From Multicenter Fetal MRI
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
Retrospective Analysis of the Neonatal Management of Patients with an Antenatal Diagnosis of Genital Development Variation At the Hospital of Lyon
Identifai Genetics Analytic Validity Study - Compound Heterozygosity and Samples Collection
The National Program for the Improvement of Management of Fetal Congenital Heart Disease in China
Postnatal Managemant of Prenetal Cardiac Echogenic Foci in Hillel Yaffe Medical Center
Influence of Prenatal Counseling in Invasive Testing
Replacement of Cytogenetics by aCGH in Prenatal Diagnosis
Comparison of Karyotyping, CMA and NIPT for Prenatal Diagnosing Chromosomal Anomalies
Does Normal Brain Imaging Predict Normal Neurodevelopmental Outcome in Fetuses With Proven Cytomegalovirus Infection?